Literature DB >> 33027550

Cardiometabolic Effects of High-Intensity Hybrid Functional Electrical Stimulation Exercise after Spinal Cord Injury.

Ryan Solinsky1,2,3, Hannah Mercier1,2, Glen Picard1, J Andrew Taylor1,2,3.   

Abstract

INTRODUCTION: The prevalence of cardiometabolic disease following spinal cord injury is known to be high. However, it is unknown whether engaging in high-intensity exercise, which is advocated by recent guidelines, is beneficial or feasible for these individuals.
OBJECTIVE: To assess the effects of high-intensity, whole-body exercise on the prevalence of cardiometabolic disease in individuals with spinal cord injury.
DESIGN: Combination of a randomized controlled trial and an open label intervention study of functional electrical stimulation legs plus arms rowing.
SETTING: Outpatient academic rehabilitation hospital. PARTICIPANTS: Forty individuals with spinal cord injury, with American Spinal Injury Association (ASIA) impairments scales A-D and neurological levels of injury C1-T12. INTERVENTION: Six months of high-intensity, hybrid-functional electrical stimulation rowing. MAIN OUTCOME MEASURES: Change in VO2max , serum lipids, and insulin resistance, prevalence of cardiometabolic disease.
RESULTS: Individuals averaged 42.1 ± 22.0 minutes of hybrid-functional electrical stimulation rowing a week over an average of 1.69 sessions per week over the 6 months of intervention. This amounted to an average of 170.9 ± 100 km rowed, at a mean heart rate of 82.7% of individualized maximum. Only one of 40 individuals met current exercise guidelines for the full 6 months. VO2max increased significantly (P < .001), yet prevalence of cardiometabolic disease did not change significantly (decrease from 22.5% to 20%, P = .70). Hemoglobin A1c did decrease significantly over this time (P = .01), although serum lipids and fasting glucose/insulin levels were unchanged. In exploratory subanalyses assessing individuals injured ≤12 months, those with more chronic injuries decreased their triglyceride-to-high-density lipoprotein (HDL) ratio (P = .04), a marker of cardiac mortality. Stratifying by neurological level of injury, individuals with paraplegia had worsened low-density lipoprotein (LDL) level (P = .02) and total cholesterol-to-HDL ratio (P = .04) over the 6-month intervention.
CONCLUSIONS: Sustained high-intensity exercise with hybrid functional electrical stimulation rowing does not decrease the prevalence of cardiometabolic disease after spinal cord injury.
© 2020 American Academy of Physical Medicine and Rehabilitation.

Entities:  

Mesh:

Year:  2020        PMID: 33027550      PMCID: PMC9284583          DOI: 10.1002/pmrj.12507

Source DB:  PubMed          Journal:  PM R        ISSN: 1934-1482            Impact factor:   2.218


  23 in total

Review 1.  Cardiovascular disease in spinal cord injury: an overview of prevalence, risk, evaluation, and management.

Authors:  Jonathan Myers; Matthew Lee; Jenny Kiratli
Journal:  Am J Phys Med Rehabil       Date:  2007-02       Impact factor: 2.159

Review 2.  Updates for the International Standards for Neurological Classification of Spinal Cord Injury.

Authors:  Steven Kirshblum; William Waring
Journal:  Phys Med Rehabil Clin N Am       Date:  2014-08       Impact factor: 1.784

3.  Correct homeostasis model assessment (HOMA) evaluation uses the computer program.

Authors:  J C Levy; D R Matthews; M P Hermans
Journal:  Diabetes Care       Date:  1998-12       Impact factor: 19.112

4.  Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study.

Authors:  I Lemieux; B Lamarche; C Couillard; A Pascot; B Cantin; J Bergeron; G R Dagenais; J P Després
Journal:  Arch Intern Med       Date:  2001 Dec 10-24

5.  Aerobic interval training reduces blood pressure and improves myocardial function in hypertensive patients.

Authors:  Harald Edvard Molmen-Hansen; Tomas Stolen; Arnt Erik Tjonna; Inger Lise Aamot; Inga Schjerve Ekeberg; Gjertrud Aunet Tyldum; Ulrik Wisloff; Charlotte Bjork Ingul; Asbjorn Stoylen
Journal:  Eur J Prev Cardiol       Date:  2011-03-04       Impact factor: 7.804

6.  Both aerobic endurance and strength training programmes improve cardiovascular health in obese adults.

Authors:  Inga E Schjerve; Gjertrud A Tyldum; Arnt E Tjønna; Tomas Stølen; Jan P Loennechen; Harald E M Hansen; Per M Haram; Garreth Heinrich; Anja Bye; Sonia M Najjar; Godfrey L Smith; Stig A Slørdahl; Ole J Kemi; Ulrik Wisløff
Journal:  Clin Sci (Lond)       Date:  2008-11       Impact factor: 6.124

7.  Effects of high- and low-intensity exercise training on aerobic capacity and blood lipids.

Authors:  G A Gaesser; R G Rich
Journal:  Med Sci Sports Exerc       Date:  1984-06       Impact factor: 5.411

8.  A guideline-driven assessment of need for cardiovascular disease risk intervention in persons with chronic paraplegia.

Authors:  Mark S Nash; Armando J Mendez
Journal:  Arch Phys Med Rehabil       Date:  2007-06       Impact factor: 3.966

Review 9.  High-intensity interval training in patients with lifestyle-induced cardiometabolic disease: a systematic review and meta-analysis.

Authors:  Kassia S Weston; Ulrik Wisløff; Jeff S Coombes
Journal:  Br J Sports Med       Date:  2013-10-21       Impact factor: 13.800

Review 10.  Exercise interventions and peripheral arterial function: implications for cardio-metabolic disease.

Authors:  Shane A Phillips; Abeer M Mahmoud; Michael D Brown; Jacob M Haus
Journal:  Prog Cardiovasc Dis       Date:  2014-12-18       Impact factor: 8.194

View more
  2 in total

1.  Hybrid Functional Electrical Stimulation Improves Anaerobic Threshold in First Three Years after Spinal Cord Injury.

Authors:  Grant Schleifer; Ryan Solinsky; J W Hamner; Glen Picard; J Andrew Taylor
Journal:  J Neurotrauma       Date:  2022-04-08       Impact factor: 4.869

2.  Effect of hybrid FES exercise on body composition during the sub-acute phase of spinal cord injury.

Authors:  Khashayar Afshari; Erin D Ozturk; Brandon Yates; Glen Picard; J Andrew Taylor
Journal:  PLoS One       Date:  2022-01-24       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.